Folks with "high-risk" bladder cancers -- tumors that had already invaded nearby muscle -- doubled the time they were ...

Findings from the international FORT-2 clinical trial showed that a combination treatment including immunotherapy is safe and ...

BARCELONA — Adding the immune checkpoint inhibitor durvalumab to standard treatment for muscle-invasive bladder cancer (MIBC) ...

An AstraZeneca immunotherapy improved survival rates in patients with bladder cancer, results that could reshape treatment of ...

A mum from Hadleigh in Suffolk who discovered she had bladder cancer in a scan is to raise money for Cancer Research UK by ...

Trodelvy in locally advanced or metastatic urothelial cancer may provide another option for those whose disease progressed ...

Some 10,000 Britons are diagnosed with bladder cancer every year, and experts warn the public is still unaware of the ...

AstraZeneca Plc’s Imfinzi extended the lives of patients with bladder cancer, potentially opening up a new market for the ...

Matthew Galsky, MD, discusses why some physicians were surprised at the positive outcomes of nivolumab trials in bladder ...

AstraZeneca’s Phase 3 study in bladder cancer, showed that giving Imfinzi — before and after surgery — cut the risk of death.

A mum from Hadleigh in Suffolk who discovered she had bladder cancer in a scan is to raise money for Cancer Research UK by running a half marathon.

Researchers compared health-related quality of life with nivolumab added to first-line chemo vs chemo alone in patients with ...